SCM
SEEL
Sarissa Capital Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-1,447,906
| Closed | -$564K | – | 10 |
|
2018
Q2 | $564K | Hold |
1,447,906
| – | – | 0.11% | 9 |
|
2018
Q1 | $587K | Hold |
1,447,906
| – | – | 0.14% | 10 |
|
2017
Q4 | $2.66M | Hold |
1,447,906
| – | – | 0.68% | 10 |
|
2017
Q3 | $2.48M | Hold |
1,447,906
| – | – | 0.76% | 7 |
|
2017
Q2 | $1.64M | Hold |
1,447,906
| – | – | 0.55% | 7 |
|
2017
Q1 | $3.06M | Hold |
1,447,906
| – | – | 1.21% | 7 |
|
2016
Q4 | $1.88M | Sell |
1,447,906
-13,031,146
| -90% | -$16.9M | 0.52% | 9 |
|
2016
Q3 | $4.9M | Hold |
14,479,052
| – | – | 1.13% | 10 |
|
2016
Q2 | $5.78M | Hold |
14,479,052
| – | – | 1.64% | 10 |
|
2016
Q1 | $8.41M | Buy |
14,479,052
+7,954,547
| +122% | +$4.62M | 1.85% | 12 |
|
2015
Q4 | $6.46M | Hold |
6,524,505
| – | – | 1.26% | 11 |
|
2015
Q3 | $9.53M | Hold |
6,524,505
| – | – | 2.35% | 11 |
|
2015
Q2 | $11.2M | Hold |
6,524,505
| – | – | 2.57% | 9 |
|
2015
Q1 | $12.2M | Buy |
6,524,505
+5,494,505
| +533% | +$10.3M | 2.57% | 9 |
|
2014
Q4 | $1.03M | Buy |
+1,030,000
| New | +$1.03M | 0.36% | 14 |
|